MSH Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.15M Buy
21,075
+318
+2% +$74.1K 1.09% 19
2025
Q4
$4.3M Buy
20,757
+5,099
+33% +$1.01M 0.92% 24
2025
Q3
$2.9M Buy
15,658
+315
+2% +$54K 0.78% 32
2025
Q2
$2.34M Buy
15,343
+354
+2% +$54.4K 0.68% 44
2025
Q1
$2.49M Buy
14,989
+106
+0.7% +$16.6K 0.77% 37
2024
Q4
$2.15M Sell
14,883
-75
-0.5% -$11.6K 0.68% 46
2024
Q3
$2.42M Buy
14,958
+84
+0.6% +$13.4K 0.74% 39
2024
Q2
$2.17M Sell
14,874
-619
-4% -$92.1K 0.73% 41
2024
Q1
$2.45M Buy
15,493
+60
+0.4% +$9.55K 0.86% 33
2023
Q4
$2.42M Sell
15,433
-1,027
-6% -$157K 0.9% 32
2023
Q3
$2.56M Buy
16,460
+133
+0.8% +$21.9K 1.01% 25
2023
Q2
$2.7M Buy
16,327
+8,236
+102% +$1.33M 0.99% 24
2023
Q1
$1.25M Sell
8,091
-36
-0.4% -$5.81K 0.54% 64
2022
Q4
$1.44M Sell
8,127
-1,025
-11% -$177K 0.65% 55
2022
Q3
$1.5M Buy
9,152
+52
+0.6% +$8.8K 0.74% 46
2022
Q2
$1.62M Buy
9,100
+1,223
+16% +$218K 0.75% 45
2022
Q1
$1.4M Buy
7,877
+966
+14% +$164K 0.58% 60
2021
Q4
$1.18M Buy
+6,911
New +$1.13M 0.53% 63

Other funds holding JNJ

MSH Capital Advisors's JNJ Position: Q1 2026 in Review

MSH Capital Advisors increased its Johnson & Johnson (JNJ) stake by 1.5% in Q1 2026, buying an estimated $74.1K and bringing the position to 21,075 shares worth $5.15M. The position accounts for 1.09% of the portfolio, ranked #19.

MSH Capital Advisors first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • MSH Capital Advisors held 21,075 shares of Johnson & Johnson worth $5.15M as of Q1 2026.
  • MSH Capital Advisors bought 318 Johnson & Johnson shares in Q1 2026, an estimated $74.1K.
  • Johnson & Johnson made up 1.09% of MSH Capital Advisors's portfolio in Q1 2026, its #19 holding.
  • MSH Capital Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on MSH Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.